Home | About CytoJournalEditorial Board | Archived articles | Search CytoJ Articles | Subscribe | Peer review policies | CytoJournal Quiz Cases
  Reviewer corner | Author corner | OA Steward’s corner | CF member’s corner | Join as CF member | Manuscript submission | Open Access (OA) Advocacy
CytoJournal All 'FULL TEXT' in HTML are FREE under "open access" charter of CytoJournal.
To login for downloading any PDF OR to request TOC (Table of Content) by e-mail, please click here
Home Email this page Print this page Small font size Default font size Increase font size Cytopathology Foundation
Navigate here
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »  Article in PDF (635 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

  In this article
 » Competing Interests
 »  List of Abbrevia...
 »  References

 Article Access Statistics
    PDF Downloaded3    
    Comments [Add]    

Recommend this journal


Browse articles
CytoJournal 2019,  16:2

Is it time to standardize fine needle aspiration of gall bladder lesions and what city name it will be stamped with?

Department of Pathology, Microbiology, and Forensic Medicine, School of Medicine, The University of Jordan, Amman, Jordan

Date of Submission07-May-2018
Date of Acceptance22-Jun-2018
Date of Web Publication22-Jan-2019

Correspondence Address:
Mousa A Al-Abbadi
Department of Pathology, Microbiology, and Forensic Medicine, School of Medicine, The University of Jordan, Amman
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/cytojournal.cytojournal_21_18

Rights and Permissions

How to cite this article:
Al-Abbadi MA. Is it time to standardize fine needle aspiration of gall bladder lesions and what city name it will be stamped with?. CytoJournal 2019;16:2

How to cite this URL:
Al-Abbadi MA. Is it time to standardize fine needle aspiration of gall bladder lesions and what city name it will be stamped with?. CytoJournal [serial online] 2019 [cited 2019 Dec 11];16:2. Available from: http://www.cytojournal.com/text.asp?2019/16/1/2/250617

In the current era of “Total Quality Management”, all stake holders in health care are trying their best to improve the standards of care coupled with attempts to reduce cost.[1],[2],[3] Although, almost all experts in the field of health care quality agree that creating and applying additional quality standards may add some extra cost; many strongly believe that long term benefits would balance these initial financial restrains.[3],[4] The quality care trends are highly infectious and pathology and laboratory medicine is not an exception. The art and science of cytopathology has been a leader in the field of standardization as we witnessed the level of quality in the Bethesda systems for the “Pap test” and thyroid in addition to the Paris system for urine cytology and the recent addition of Milan system for salivary gland cytology.[5],[6],[7],[8]

In the current issue of CytoJournal, Chandra et al. attempted to plant the initial seeds to standardize the terminology of aspirate smears from gall bladder lesions.[9] They retrospectively reviewed 433 fine needle aspirate smears from gall bladder lesions in their institutions followed up by cytohistological correlation analysis for 93 cases where tissue diagnosis was available with a cytohistological concordance of 94%. Their cytomorphological review included objective analysis of multiple parameters. These included architectural patterns, cellular morphology, nuclear features and the type of background material. Similar to the terminology utilized in other systems; they proposed 5 distinct major categories: Category I: Inadequate, Category II: Benign, Category III: Atypical, Category IV) Atypical suggestive or suspicious for malignancy, and Category V: Malignant. The inadequate category in this study comprised 7.8% which is essentially an acceptable rate given the peculiarities of these aspirates where in few cases the procurement of diagnostic material is either acellular or unsatisfactory to make a reasonable interpretation. The second category was the essentially the negative cases where the interpretation included reactive cases, inflammatory conditions and benign neoplasms. And this category comprised 11.5% of their cases. Almost less than 10% of the cases represented the equivocal cases where definitive diagnosis could not be reached. The first one is the atypical category where the atypia was mild enough not to raise suspicious of malignancy and the authors recommended repeat aspiration taking into consideration the clinical and radiological features of these patients. The second one of this group is those cases where there was enough atypia crossing the threshold to raise suspicion of malignancy. Although the authors placed these categories in an equivocal box; we believe that their low rate (less than 10% for both category III and IV) is quite reasonable. Consequently; the follow up approach would likely depend on the degree of clinical and radiological suspicion of such cases where repeat aspiration or tissue biopsy would give a more definitive diagnosis. The fifth category was the positive cases where the cytomorphological criteria were met and this group was the most common where it comprised 71% of the study population cases.

The authors went further and tried to sub-classify their positive cases into a more specific diagnosis of malignancy including papillary, mucinous, small cell and poorly differentiated carcinoma. This latest attempt by authors, although sometimes helpful, we believe that this additional sub-classification might be included in a final comment, rather in the main stem diagnosis.

As expected, the lowest concordance rate was for category IV (80% cytohistological concordance rate), where 4 cases revealed a benign diagnosis. However, and as mentioned before, this category was relatively small and only comprised 4.3% of the study population. A previous trial to utilize the WHO histological classification of gall bladder carcinoma was attempted on a comparable number of cases but without delving into standardizing the terminology.[10]

In conclusion; the authors are commended in their attempt to standardize the interpretation categories for gall bladder lesions fine needle aspiration cytology. The study was based on objective cytomorphological criteria emphasizing evidence-based cytology.[11] We hope that this study will entice more efforts to add on the current authors findings. If the domino effect prevails here; it will be interesting to see which name this gall bladder cytology system will carry.

The authors are to be commended on their efforts on this well-written manuscript and their attempt to entice standardization of gall bladder lesions FNA.

 » Competing Interests Top

The authors declare that they have no competing interests.

 » List of Abbreviations (In Alphabetic Order) Top

FNA – Fine needle aspiration

Pap – Papanicolaou.

 » References Top

Carman JM, Shortell SM, Foster RW, Hughes EF, Boerstler H, O' Brien JL, et al. Keys for successful implementation of total quality management in hospitals. Health Care Manage Rev 2010;35:283-93.  Back to cited text no. 1
Branco D, Wicks AM, Visich JK. Using quality tools and methodologies to improve a hospital's quality position. Hosp Top 2017;95:10-7.  Back to cited text no. 2
Spencer G. Making the move to an ACO. Healthc Financ Manage 2014;68:92-6.  Back to cited text no. 3
Øvretveit J. The economics of quality – A practical approach. Int J Health Care Qual Assur Inc Leadersh Health Serv 2000;13:200-7.  Back to cited text no. 4
Nayar R, Wilbur DC. The pap test and Bethesda 2014. “The reports of my demise have been greatly exaggerated.” (after a quotation from mark Twain). Acta Cytol 2015;59:121-32.  Back to cited text no. 5
Ali SZ. Thyroid cytopathology: Bethesda and beyond. Acta Cytol 2011;55:4-12.  Back to cited text no. 6
Barkan GA, Wojcik EM, Nayar R, Savic-Prince S, Quek ML, Kurtycz DF, et al. The Paris system for reporting urinary cytology: The quest to develop a standardized terminology. Adv Anat Pathol 2016;23:193-201.  Back to cited text no. 7
Rossi ED, Faquin WC, Baloch Z, Barkan GA, Foschini MP, Pusztaszeri M, et al. The Milan system for reporting salivary gland cytopathology: Analysis and suggestions of initial survey. Cancer Cytopathol 2017;125:757-66.  Back to cited text no. 8
Chandra S, Chandra H, Shukla SK, Sahu S. Fine needle aspiration of gall bladder with an attempt of cyto-histological classification. Cytojournal [In Press].  Back to cited text no. 9
Yadav R, Jain D, Mathur SR, Sharma A, Iyer VK. Gallbladder carcinoma: An attempt of WHO histological classification on fine needle aspiration material. Cytojournal 2013;10:12.  Back to cited text no. 10
[PUBMED]  [Full text]  
Dey P. Time for evidence-based cytology. Cytojournal 2007;4:1.  Back to cited text no. 11
[PUBMED]  [Full text]  


Previous article Next article


  Site Map | Copyright and Disclaimer
© 2007 - CytoJournal | A journal by Cytopathology Foundation Inc with Wolters Kluwer - Medknow
New version online since 1st July '08
Open Access